Aztreonam–avibactam versus meropenem for the treatment of serious infections caused by Gram-negative bacteria (REVISIT) : a descriptive, multinational, open-label, phase 3, randomised trial
Source
The lancet infectious diseases - ISSN 1473-3099-25:2 (2025) p. 218-230
The effect of a general practitioner’s perception of a patient request for antibiotics on antibiotic prescribing for respiratory tract infections : secondary analysis of a point prevalence audit survey in 18 European countries
Source
BJGP Open - ISSN 2398-3795- (2025) p.
Genomic epidemiological analysis of a single-centre polyclonal outbreak of Serratia marcescens, Belgium, 2022 to 2023
Source
Eurosurveillance : European communicable disease bulletin - ISSN 1025-496X-29:48 (2024) p. 1-10
Tracing carriage, acquisition, and transmission of ESBL-producing Escherichia coli over two years in a tertiary care hospital
Source
Genome medicine - ISSN 1756-994X-16:1 (2024) p. 1-15
A longitudinal point prevalence survey of antimicrobial use and resistance in tertiary care hospitals in Kerman : results from the national Iranian multicenter point prevalence survey of antimicrobials in 2021
Source
BMC infectious diseases - ISSN 1471-2334-24:1 (2024) p. 1-6